← All drugs
Drug

Estradiol/norethindrone Acetate

73 flagged reaction(s) · 1,237 total co-reports · max PRR 78.1
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Breast Cancer Female 191 78.1 86.6 signal
2 Breast Cancer Metastatic 44 45.0 46.0 signal
3 Breast Cancer 281 32.7 38.2 signal
4 Bursitis 20 18.1 18.3 signal
5 Body Temperature Decreased 16 17.6 17.8 signal
6 Brain Fog 20 15.0 15.1 signal
7 Hypokinesia 17 12.8 12.9 signal
8 Bone Density Decreased 32 11.0 11.2 signal
9 Menorrhagia 20 11.0 11.1 signal
10 Blood Pressure Systolic Increased 19 10.6 10.7 signal
11 Middle Insomnia 18 10.6 10.7 signal
12 Deformity 9 10.5 10.5 signal
13 Breast Pain 10 10.3 10.3 signal
14 Product Administration Error 18 9.9 9.9 signal
15 Vaginal Haemorrhage 35 9.0 9.1 signal
16 Abnormal Dreams 21 8.3 8.3 signal
17 Abdominal Pain Lower 18 7.8 7.8 signal
18 Micturition Urgency 8 7.7 7.7 signal
19 Hot Flush 51 7.4 7.6 signal
20 Heart Rate Decreased 23 7.1 7.2 signal
21 Dental Caries 7 6.9 6.9 signal
22 Blood Potassium Decreased 19 6.9 7.0 signal
23 Obesity 9 6.2 6.2 signal
24 Tooth Fracture 6 5.9 6.0 signal
25 Nerve Compression 5 5.9 5.9 signal
26 Joint Injury 11 5.6 5.6 signal
27 Poor Quality Sleep 11 5.6 5.6 signal
28 Vitreous Floaters 5 5.6 5.6 signal
29 Gingival Bleeding 7 5.6 5.6 signal
30 Pneumocystis Jirovecii Pneumonia 5 5.5 5.5 signal
31 Pelvic Pain 9 5.4 5.4 signal
32 Secretion Discharge 6 5.3 5.3 signal
33 Thyroid Disorder 7 5.0 5.0 signal
34 Drug Dispensing Error 7 4.9 4.9 signal
35 Hypertensive Crisis 5 4.9 4.9 signal
36 Tooth Disorder 10 4.9 4.9 signal
37 Blood Thyroid Stimulating Hormone Increased 4 4.7 4.7 signal
38 Ovarian Cancer 4 4.7 4.7 signal
39 Skin Reaction 6 4.7 4.7 signal
40 Blood Pressure Fluctuation 10 4.5 4.6 signal
41 Metrorrhagia 7 4.4 4.4 signal
42 Application Site Irritation 5 4.4 4.4 signal
43 Vaginal Discharge 4 4.3 4.4 signal
44 Bone Loss 6 4.3 4.3 signal
45 Dry Throat 4 4.3 4.3 signal
46 Needle Issue 11 4.2 4.2 signal
47 Dysmenorrhoea 5 4.2 4.2 signal
48 Drug Administered At Inappropriate Site 4 4.1 4.1 signal
49 Back Disorder 6 4.0 4.0 signal
50 Lip Swelling 12 3.9 4.0 signal
51 Intestinal Perforation 4 3.9 3.9 signal
52 Local Swelling 6 3.7 3.7 signal
53 Abnormal Weight Gain 4 3.5 3.5 signal
54 Breast Cancer Stage I 3 3.5 3.5 no signal
55 Abortion Induced 3 3.5 3.5 no signal
56 Application Site Erythema 8 3.3 3.3 signal
57 Angioedema 13 3.2 3.2 signal
58 Akathisia 4 3.2 3.2 signal
59 Emotional Disorder 9 3.2 3.2 signal
60 Application Site Rash 4 3.2 3.2 no signal
61 Bipolar Disorder 3 3.0 3.0 no signal
62 Pharmaceutical Product Complaint 7 2.9 2.9 signal
63 Madarosis 3 2.8 2.8 no signal
64 Product Adhesion Issue 9 2.8 2.8 signal
65 Acne 18 2.6 2.6 signal
66 Product Dispensing Error 5 2.5 2.5 no signal
67 Product Substitution Issue 13 2.5 2.5 signal
68 Osteonecrosis Of Jaw 5 2.2 2.2 no signal
69 Incorrect Drug Administration Duration 4 1.5 1.5 no signal
70 Application Site Pruritus 3 1.4 1.4 no signal
71 Multiple Sclerosis Relapse 9 1.4 1.4 no signal
72 Injection Site Mass 4 1.2 1.2 no signal
73 Drug Withdrawal Syndrome 8 1.0 1.0 no signal